10-K Filing

TENET HEALTHCARE CORP CIK: 70318 FY 2017

Filing Information

Form Type	10-K
Accession Number	`0000070318-18-000011`
Period End Date	20171231
Filing Date	20180226
Fiscal Year	2017
Fiscal Period	FY
XBRL Instance	thc-20171231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 95 Income Statement 111 Cash Flow Statement 140 Stockholders Equity 28 Comprehensive Income 33

Balance Sheet 95 line items

Line Item	Tag	Value	Unit	Period
Accounts receivable, allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$898.00M	USD	Point-in-time
Accounts receivable, allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$1.03B	USD	Point-in-time
Property and equipment, accumulated depreciation and amortization	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$4.97B	USD	Point-in-time
Property and equipment, accumulated depreciation and amortization	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$4.74B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$716.00M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$356.00M	USD	Point-in-time
Other intangible assets, accumulated amortization	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$772.00M	USD	Point-in-time
Other intangible assets, accumulated amortization	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$883.00M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$611.00M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$193.00M	USD	Point-in-time
Accounts receivable, less allowance for doubtful accounts ($898 at December 31, 2017 and $1,031 at December 31, 2016)	`AccountsReceivableNetCurrent`	$2.90B	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.05	USD	Point-in-time
Accounts receivable, less allowance for doubtful accounts ($898 at December 31, 2017 and $1,031 at December 31, 2016)	`AccountsReceivableNetCurrent`	$2.62B	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.05	USD	Point-in-time
Inventories of supplies, at cost	`InventoryNet`	$289.00M	USD	Point-in-time
Common stock, authorized shares (in shares)	`CommonStockSharesAuthorized`	262.50M	shares	Point-in-time
Inventories of supplies, at cost	`InventoryNet`	$326.00M	USD	Point-in-time
Common stock, authorized shares (in shares)	`CommonStockSharesAuthorized`	262.50M	shares	Point-in-time
Income tax receivable	`IncomeTaxesReceivable`	$4.00M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	149.38M	shares	Point-in-time
Income tax receivable	`IncomeTaxesReceivable`	$5.00M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	148.11M	shares	Point-in-time
Common stock in treasury, shares (in shares)	`TreasuryStockCommonShares`	48.42M	shares	Point-in-time
Common stock in treasury, shares (in shares)	`TreasuryStockCommonShares`	48.41M	shares	Point-in-time
Assets held for sale	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$29.00M	USD	Point-in-time
Assets held for sale	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$1.02B	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$1.03B	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$1.28B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$5.26B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$5.57B	USD	Point-in-time
Investments and other assets	`LongTermInvestmentsAndReceivablesNet`	$1.25B	USD	Point-in-time
Investments and other assets	`LongTermInvestmentsAndReceivablesNet`	$1.54B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxAssetsNet`	$871.00M	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxAssetsNet`	$455.00M	USD	Point-in-time
Property and equipment, at cost, less accumulated depreciation and amortization ($4,739 at December 31, 2017 and $4,974 at December 31, 2016)	`PropertyPlantAndEquipmentNet`	$7.03B	USD	Point-in-time
Property and equipment, at cost, less accumulated depreciation and amortization ($4,739 at December 31, 2017 and $4,974 at December 31, 2016)	`PropertyPlantAndEquipmentNet`	$8.05B	USD	Point-in-time
Goodwill	`Goodwill`	$7.02B	USD	Point-in-time
Goodwill	`Goodwill`	$7.42B	USD	Point-in-time
Other intangible assets, at cost, less accumulated amortization ($883 at December 31, 2017 and $772 at December 31, 2016)	`IntangibleAssetsNetExcludingGoodwill`	$1.84B	USD	Point-in-time
Other intangible assets, at cost, less accumulated amortization ($883 at December 31, 2017 and $772 at December 31, 2016)	`IntangibleAssetsNetExcludingGoodwill`	$1.77B	USD	Point-in-time
Total assets	`Assets`	$23.39B	USD	Point-in-time
Total assets	`Assets`	$23.68B	USD	Point-in-time
Total assets	`Assets`	$24.70B	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$191.00M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$146.00M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.18B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.33B	USD	Point-in-time
Accrued compensation and benefits	`EmployeeRelatedLiabilitiesCurrent`	$848.00M	USD	Point-in-time
Accrued compensation and benefits	`EmployeeRelatedLiabilitiesCurrent`	$872.00M	USD	Point-in-time
Professional and general liability reserves	`SelfInsuranceReserveCurrent`	$200.00M	USD	Point-in-time
Professional and general liability reserves	`SelfInsuranceReserveCurrent`	$181.00M	USD	Point-in-time
Accrued interest payable	`InterestPayableCurrent`	$210.00M	USD	Point-in-time
Accrued interest payable	`InterestPayableCurrent`	$256.00M	USD	Point-in-time
Liabilities held for sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$480.00M	USD	Point-in-time
Liabilities held for sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$9.00M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$1.24B	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$1.23B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.33B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.03B	USD	Point-in-time
Long-term debt, net of current portion	`LongTermDebtAndCapitalLeaseObligations`	$14.79B	USD	Point-in-time
Long-term debt, net of current portion	`LongTermDebtAndCapitalLeaseObligations`	$15.06B	USD	Point-in-time
Professional and general liability reserves	`SelfInsuranceReserveNoncurrent`	$654.00M	USD	Point-in-time
Professional and general liability reserves	`SelfInsuranceReserveNoncurrent`	$613.00M	USD	Point-in-time
Defined benefit plan obligations	`PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent`	$626.00M	USD	Point-in-time
Defined benefit plan obligations	`PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent`	$536.00M	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$36.00M	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$279.00M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$631.00M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$610.00M	USD	Point-in-time
Total liabilities	`Liabilities`	$20.98B	USD	Point-in-time
Total liabilities	`Liabilities`	$21.23B	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Redeemable noncontrolling interests in equity of consolidated subsidiaries	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$2.39B	USD	Point-in-time
Redeemable noncontrolling interests in equity of consolidated subsidiaries	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$1.87B	USD	Point-in-time
Common stock, $0.05 par value; authorized 262,500,000 shares; 149,384,952 shares issued at December 31, 2017 and 148,106,249 shares issued at December 31, 2016	`CommonStockValue`	$7.00M	USD	Point-in-time
Common stock, $0.05 par value; authorized 262,500,000 shares; 149,384,952 shares issued at December 31, 2017 and 148,106,249 shares issued at December 31, 2016	`CommonStockValue`	$7.00M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$4.86B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$4.83B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-258.00M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-204.00M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.74B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-2.39B	USD	Point-in-time
Common stock in treasury, at cost, 48,413,169 shares at December 31, 2017 and 48,420,650 shares at December 31, 2016	`TreasuryStockCommonValue`	$2.42B	USD	Point-in-time
Common stock in treasury, at cost, 48,413,169 shares at December 31, 2017 and 48,420,650 shares at December 31, 2016	`TreasuryStockCommonValue`	$2.42B	USD	Point-in-time
Total shareholders equity (deficit)	`StockholdersEquity`	$-147.00M	USD	Point-in-time
Total shareholders equity (deficit)	`StockholdersEquity`	$417.00M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$665.00M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$686.00M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.08B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$539.00M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$785.00M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$958.00M	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$24.70B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$23.39B	USD	Point-in-time

Income Statement 111 line items

Line Item	Tag	Value	Unit	Period
Net operating revenues before provision for doubtful accounts	`HealthCareOrganizationRevenue`	$20.11B	USD	Annual
Net operating revenues before provision for doubtful accounts	`HealthCareOrganizationRevenue`	$21.07B	USD	Annual
Net operating revenues before provision for doubtful accounts	`HealthCareOrganizationRevenue`	$20.61B	USD	Annual
Less: Provision for doubtful accounts	`HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts`	$1.43B	USD	Annual
Less: Provision for doubtful accounts	`HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts`	$1.45B	USD	Annual
Less: Provision for doubtful accounts	`HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts`	$1.48B	USD	Annual
Net operating revenues	`HealthCareOrganizationRevenueNetOfPatientServiceRevenueProvisions`	$19.62B	USD	Annual
Net operating revenues	`HealthCareOrganizationRevenueNetOfPatientServiceRevenueProvisions`	$18.63B	USD	Annual
Net operating revenues	`HealthCareOrganizationRevenueNetOfPatientServiceRevenueProvisions`	$19.18B	USD	Annual
Equity in earnings of unconsolidated affiliates	`IncomeLossFromEquityMethodInvestments`	$144.00M	USD	Annual
Equity in earnings of unconsolidated affiliates	`IncomeLossFromEquityMethodInvestments`	$99.00M	USD	Annual
Equity in earnings of unconsolidated affiliates	`IncomeLossFromEquityMethodInvestments`	$131.00M	USD	Annual
Salaries, wages and benefits	`LaborAndRelatedExpense`	$9.33B	USD	Annual
Salaries, wages and benefits	`LaborAndRelatedExpense`	$9.27B	USD	Annual
Salaries, wages and benefits	`LaborAndRelatedExpense`	$8.99B	USD	Annual
Supplies	`HealthCareOrganizationMedicalSuppliesAndDrugsExpense`	$3.08B	USD	Annual
Supplies	`HealthCareOrganizationMedicalSuppliesAndDrugsExpense`	$2.96B	USD	Annual
Supplies	`HealthCareOrganizationMedicalSuppliesAndDrugsExpense`	$3.12B	USD	Annual
Other operating expenses, net	`OtherCostAndExpenseOperating`	$4.55B	USD	Annual
Other operating expenses, net	`OtherCostAndExpenseOperating`	$4.57B	USD	Annual
Other operating expenses, net	`OtherCostAndExpenseOperating`	$4.89B	USD	Annual
Electronic health record incentives	`ElectronicHealthRecordIncentives`	$9.00M	USD	Annual
Electronic health record incentives	`ElectronicHealthRecordIncentives`	$72.00M	USD	Annual
Electronic health record incentives	`ElectronicHealthRecordIncentives`	$32.00M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$797.00M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$870.00M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$850.00M	USD	Annual
Impairment and restructuring charges, and acquisition-related costs	`RestructuringSettlementImpairmentProvisionsAndAcquisitionCost`	$541.00M	USD	Annual
Impairment and restructuring charges, and acquisition-related costs	`RestructuringSettlementImpairmentProvisionsAndAcquisitionCost`	$318.00M	USD	Annual
Impairment and restructuring charges, and acquisition-related costs	`RestructuringSettlementImpairmentProvisionsAndAcquisitionCost`	$202.00M	USD	Annual
Litigation and investigation costs	`GainLossRelatedToLitigationSettlement`	$-291.00M	USD	Annual
Litigation and investigation costs	`GainLossRelatedToLitigationSettlement`	$-293.00M	USD	Annual
Litigation and investigation costs	`GainLossRelatedToLitigationSettlement`	$-23.00M	USD	Annual
Gains on sales, consolidation and deconsolidation of facilities	`GainLossOnSaleConsolidationAndDeconsolidationOfFacilities`	$186.00M	USD	Annual
Gains on sales, consolidation and deconsolidation of facilities	`GainLossOnSaleConsolidationAndDeconsolidationOfFacilities`	$144.00M	USD	Annual
Gains on sales, consolidation and deconsolidation of facilities	`GainLossOnSaleConsolidationAndDeconsolidationOfFacilities`	$151.00M	USD	Annual
Operating income	`OperatingIncomeLoss`	$1.11B	USD	Annual
Operating income	`OperatingIncomeLoss`	$1.25B	USD	Annual
Operating income	`OperatingIncomeLoss`	$1.08B	USD	Annual
Interest expense	`InterestExpense`	$979.00M	USD	Annual
Interest expense	`InterestExpense`	$1.03B	USD	Annual
Interest expense	`InterestExpense`	$912.00M	USD	Annual
Other non-operating expense, net	`OtherNonoperatingExpense`	$20.00M	USD	Annual
Other non-operating expense, net	`OtherNonoperatingExpense`	$20.00M	USD	Annual
Other non-operating expense, net	`OtherNonoperatingExpense`	$22.00M	USD	Annual
Loss from early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-1.00M	USD	Annual
Loss from early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Loss from early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-164.00M	USD	Annual
Income (loss) from continuing operations, before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-101.00M	USD	Annual
Income (loss) from continuing operations, before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$248.00M	USD	Annual
Income (loss) from continuing operations, before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$144.00M	USD	Annual
Income tax expense	`IncomeTaxExpenseBenefit`	$219.00M	USD	Annual
Income tax expense	`IncomeTaxExpenseBenefit`	$67.00M	USD	Annual
Income tax expense	`IncomeTaxExpenseBenefit`	$68.00M	USD	Annual
Income (loss) from continuing operations, before discontinued operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$181.00M	USD	Annual
Income (loss) from continuing operations, before discontinued operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-320.00M	USD	Annual
Income (loss) from continuing operations, before discontinued operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$76.00M	USD	Annual
Loss from operations	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax`	$-5.00M	USD	Annual
Loss from operations	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax`	-	USD	Annual
Loss from operations	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax`	$-6.00M	USD	Annual
Litigation and investigation benefit	`DisposalGroupIncludingDiscontinuedOperationLitigationAndInvestigationExpense`	$8.00M	USD	Annual
Litigation and investigation benefit	`DisposalGroupIncludingDiscontinuedOperationLitigationAndInvestigationExpense`	-	USD	Annual
Litigation and investigation benefit	`DisposalGroupIncludingDiscontinuedOperationLitigationAndInvestigationExpense`	-	USD	Annual
Income tax benefit (expense)	`DiscontinuedOperationTaxEffectOfDiscontinuedOperation`	$-1.00M	USD	Annual
Income tax benefit (expense)	`DiscontinuedOperationTaxEffectOfDiscontinuedOperation`	-	USD	Annual
Income tax benefit (expense)	`DiscontinuedOperationTaxEffectOfDiscontinuedOperation`	$1.00M	USD	Annual
Income (loss) from discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-5.00M	USD	Annual
Income (loss) from discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$2.00M	USD	Annual
Income (loss) from discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTax`	-	USD	Annual
Net income (loss)	`ProfitLoss`	$-320.00M	USD	Annual
Net income (loss)	`ProfitLoss`	$78.00M	USD	Annual
Net income (loss)	`ProfitLoss`	$176.00M	USD	Annual
Less: Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$384.00M	USD	Annual
Less: Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$218.00M	USD	Annual
Less: Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$368.00M	USD	Annual
Net loss attributable to Tenet Healthcare Corporation common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-704.00M	USD	Annual
Net loss attributable to Tenet Healthcare Corporation common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-192.00M	USD	Annual
Net loss attributable to Tenet Healthcare Corporation common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-140.00M	USD	Annual
Loss from continuing operations, net of tax	`IncomeLossFromContinuingOperations`	$-187.00M	USD	Annual
Loss from continuing operations, net of tax	`IncomeLossFromContinuingOperations`	$-142.00M	USD	Annual
Loss from continuing operations, net of tax	`IncomeLossFromContinuingOperations`	$-704.00M	USD	Annual
Income (loss) from discontinued operations, net of tax	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$-5.00M	USD	Annual
Income (loss) from discontinued operations, net of tax	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$2.00M	USD	Annual
Income (loss) from discontinued operations, net of tax	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	-	USD	Annual
Net loss attributable to Tenet Healthcare Corporation common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-704.00M	USD	Annual
Net loss attributable to Tenet Healthcare Corporation common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-192.00M	USD	Annual
Net loss attributable to Tenet Healthcare Corporation common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-140.00M	USD	Annual
Continuing operations (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$-1.43	USD	Annual
Continuing operations (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$-1.88	USD	Annual
Continuing operations (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$-7.00	USD	Annual
Discontinued operations (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	$-0.05	USD	Annual
Discontinued operations (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	$0.02	USD	Annual
Discontinued operations (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	-	USD	Annual
Total loss per share, Basic (in dollars per share)	`EarningsPerShareBasic`	$-1.93	USD	Annual
Total loss per share, Basic (in dollars per share)	`EarningsPerShareBasic`	$-1.41	USD	Annual
Total loss per share, Basic (in dollars per share)	`EarningsPerShareBasic`	$-7.00	USD	Annual
Continuing operations (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-7.00	USD	Annual
Continuing operations (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-1.88	USD	Annual
Continuing operations (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-1.43	USD	Annual
Discontinued operations (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	$0.02	USD	Annual
Discontinued operations (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	$-0.05	USD	Annual
Discontinued operations (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	-	USD	Annual
Total loss per share, Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-7.00	USD	Annual
Total loss per share, Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-1.93	USD	Annual
Total loss per share, Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-1.41	USD	Annual
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	100.59M	shares	Annual
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	99.32M	shares	Annual
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	99.17M	shares	Annual
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	100.59M	shares	Annual
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	99.17M	shares	Annual
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	99.32M	shares	Annual

Cash Flow Statement 140 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$-320.00M	USD	Annual
Net income (loss)	`ProfitLoss`	$78.00M	USD	Annual
Net income (loss)	`ProfitLoss`	$176.00M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$797.00M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$870.00M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$850.00M	USD	Annual
Provision for doubtful accounts	`HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts`	$1.43B	USD	Annual
Provision for doubtful accounts	`HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts`	$1.45B	USD	Annual
Provision for doubtful accounts	`HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts`	$1.48B	USD	Annual
Deferred income tax expense	`DeferredIncomeTaxExpenseBenefit`	$200.00M	USD	Annual
Deferred income tax expense	`DeferredIncomeTaxExpenseBenefit`	$41.00M	USD	Annual
Deferred income tax expense	`DeferredIncomeTaxExpenseBenefit`	$42.00M	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$69.00M	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$59.00M	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$68.00M	USD	Annual
Impairment and restructuring charges, and acquisition-related costs	`RestructuringSettlementImpairmentProvisionsAndAcquisitionCost`	$541.00M	USD	Annual
Impairment and restructuring charges, and acquisition-related costs	`RestructuringSettlementImpairmentProvisionsAndAcquisitionCost`	$318.00M	USD	Annual
Impairment and restructuring charges, and acquisition-related costs	`RestructuringSettlementImpairmentProvisionsAndAcquisitionCost`	$202.00M	USD	Annual
Litigation and investigation costs	`GainLossRelatedToLitigationSettlement`	$-291.00M	USD	Annual
Litigation and investigation costs	`GainLossRelatedToLitigationSettlement`	$-293.00M	USD	Annual
Litigation and investigation costs	`GainLossRelatedToLitigationSettlement`	$-23.00M	USD	Annual
Gains on sales, consolidation and deconsolidation of facilities	`GainLossOnSaleConsolidationAndDeconsolidationOfFacilities`	$186.00M	USD	Annual
Gains on sales, consolidation and deconsolidation of facilities	`GainLossOnSaleConsolidationAndDeconsolidationOfFacilities`	$144.00M	USD	Annual
Gains on sales, consolidation and deconsolidation of facilities	`GainLossOnSaleConsolidationAndDeconsolidationOfFacilities`	$151.00M	USD	Annual
Loss from early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-1.00M	USD	Annual
Loss from early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Loss from early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-164.00M	USD	Annual
Equity in earnings of unconsolidated affiliates, net of distributions received	`IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions`	$18.00M	USD	Annual
Equity in earnings of unconsolidated affiliates, net of distributions received	`IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions`	$13.00M	USD	Annual
Equity in earnings of unconsolidated affiliates, net of distributions received	`IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions`	$99.00M	USD	Annual
Amortization of debt discount and debt issuance costs	`AmortizationOfFinancingCostsAndDiscounts`	$41.00M	USD	Annual
Amortization of debt discount and debt issuance costs	`AmortizationOfFinancingCostsAndDiscounts`	$44.00M	USD	Annual
Amortization of debt discount and debt issuance costs	`AmortizationOfFinancingCostsAndDiscounts`	$41.00M	USD	Annual
Pre-tax (income) loss from discontinued operations	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax`	$-6.00M	USD	Annual
Pre-tax (income) loss from discontinued operations	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax`	$3.00M	USD	Annual
Pre-tax (income) loss from discontinued operations	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax`	-	USD	Annual
Other items, net	`OtherNoncashIncomeExpense`	$-59.00M	USD	Annual
Other items, net	`OtherNoncashIncomeExpense`	$18.00M	USD	Annual
Other items, net	`OtherNoncashIncomeExpense`	$1.00M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$1.60B	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$1.45B	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$1.63B	USD	Annual
Inventories and other current assets	`IncreaseDecreaseInInventoriesAndOtherAssetsCurrent`	$130.00M	USD	Annual
Inventories and other current assets	`IncreaseDecreaseInInventoriesAndOtherAssetsCurrent`	$35.00M	USD	Annual
Inventories and other current assets	`IncreaseDecreaseInInventoriesAndOtherAssetsCurrent`	$83.00M	USD	Annual
Income taxes	`IncreaseDecreaseInIncomeTaxesReceivable`	$38.00M	USD	Annual
Income taxes	`IncreaseDecreaseInIncomeTaxesReceivable`	$8.00M	USD	Annual
Income taxes	`IncreaseDecreaseInIncomeTaxesReceivable`	$-18.00M	USD	Annual
Accounts payable, accrued expenses and other current liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$68.00M	USD	Annual
Accounts payable, accrued expenses and other current liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-51.00M	USD	Annual
Accounts payable, accrued expenses and other current liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-10.00M	USD	Annual
Other long-term liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$26.00M	USD	Annual
Other long-term liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$40.00M	USD	Annual
Other long-term liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$38.00M	USD	Annual
Payments for restructuring charges, acquisition-related costs, and litigation costs and settlements	`PaymentsForRestructuringAndLitigationCosts`	$200.00M	USD	Annual
Payments for restructuring charges, acquisition-related costs, and litigation costs and settlements	`PaymentsForRestructuringAndLitigationCosts`	$691.00M	USD	Annual
Payments for restructuring charges, acquisition-related costs, and litigation costs and settlements	`PaymentsForRestructuringAndLitigationCosts`	$125.00M	USD	Annual
Net cash used in operating activities from discontinued operations, excluding income taxes	`CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations`	$-5.00M	USD	Annual
Net cash used in operating activities from discontinued operations, excluding income taxes	`CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations`	$-21.00M	USD	Annual
Net cash used in operating activities from discontinued operations, excluding income taxes	`CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations`	$-6.00M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$1.03B	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$558.00M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$1.20B	USD	Annual
Purchases of property and equipment continuing operations	`PaymentsToAcquirePropertyPlantAndEquipment`	$842.00M	USD	Annual
Purchases of property and equipment continuing operations	`PaymentsToAcquirePropertyPlantAndEquipment`	$875.00M	USD	Annual
Purchases of property and equipment continuing operations	`PaymentsToAcquirePropertyPlantAndEquipment`	$707.00M	USD	Annual
Purchases of businesses or joint venture interests, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$50.00M	USD	Annual
Purchases of businesses or joint venture interests, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$940.00M	USD	Annual
Purchases of businesses or joint venture interests, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$117.00M	USD	Annual
Proceeds from sales of facilities and other assets	`ProceedsFromDivestitureOfBusinesses`	$827.00M	USD	Annual
Proceeds from sales of facilities and other assets	`ProceedsFromDivestitureOfBusinesses`	$549.00M	USD	Annual
Proceeds from sales of facilities and other assets	`ProceedsFromDivestitureOfBusinesses`	$573.00M	USD	Annual
Proceeds from sales of marketable securities, long-term investments and other assets	`ProceedsFromSaleOfMarketableSecuritiesLongTermInvestmentsAndOtherAssets`	$60.00M	USD	Annual
Proceeds from sales of marketable securities, long-term investments and other assets	`ProceedsFromSaleOfMarketableSecuritiesLongTermInvestmentsAndOtherAssets`	$36.00M	USD	Annual
Proceeds from sales of marketable securities, long-term investments and other assets	`ProceedsFromSaleOfMarketableSecuritiesLongTermInvestmentsAndOtherAssets`	$62.00M	USD	Annual
Purchases of equity investments	`PaymentsToAcquireEquityMethodInvestments`	$68.00M	USD	Annual
Purchases of equity investments	`PaymentsToAcquireEquityMethodInvestments`	$39.00M	USD	Annual
Purchases of equity investments	`PaymentsToAcquireEquityMethodInvestments`	$134.00M	USD	Annual
Other long-term assets	`PaymentsForProceedsFromProductiveAssets`	$4.00M	USD	Annual
Other long-term assets	`PaymentsForProceedsFromProductiveAssets`	$31.00M	USD	Annual
Other long-term assets	`PaymentsForProceedsFromProductiveAssets`	$10.00M	USD	Annual
Other items, net	`PaymentsForProceedsFromOtherInvestingActivities`	$7.00M	USD	Annual
Other items, net	`PaymentsForProceedsFromOtherInvestingActivities`	$6.00M	USD	Annual
Other items, net	`PaymentsForProceedsFromOtherInvestingActivities`	$3.00M	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$21.00M	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-1.32B	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-430.00M	USD	Annual
Repayments of borrowings under credit facility	`RepaymentsOfLongTermLinesOfCredit`	$2.81B	USD	Annual
Repayments of borrowings under credit facility	`RepaymentsOfLongTermLinesOfCredit`	$970.00M	USD	Annual
Repayments of borrowings under credit facility	`RepaymentsOfLongTermLinesOfCredit`	$1.90B	USD	Annual
Proceeds from borrowings under credit facility	`ProceedsFromLongTermLinesOfCredit`	$970.00M	USD	Annual
Proceeds from borrowings under credit facility	`ProceedsFromLongTermLinesOfCredit`	$1.90B	USD	Annual
Proceeds from borrowings under credit facility	`ProceedsFromLongTermLinesOfCredit`	$2.60B	USD	Annual
Repayments of other borrowings	`RepaymentsOfLongTermDebtAndCapitalSecurities`	$154.00M	USD	Annual
Repayments of other borrowings	`RepaymentsOfLongTermDebtAndCapitalSecurities`	$4.14B	USD	Annual
Repayments of other borrowings	`RepaymentsOfLongTermDebtAndCapitalSecurities`	$2.05B	USD	Annual
Proceeds from other borrowings	`ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet`	$3.79B	USD	Annual
Proceeds from other borrowings	`ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet`	$760.00M	USD	Annual
Proceeds from other borrowings	`ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet`	$3.16B	USD	Annual
Repurchases of common stock	`PaymentsForRepurchaseOfCommonStock`	-	USD	Annual
Repurchases of common stock	`PaymentsForRepurchaseOfCommonStock`	-	USD	Annual
Repurchases of common stock	`PaymentsForRepurchaseOfCommonStock`	$40.00M	USD	Annual
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$12.00M	USD	Annual
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$62.00M	USD	Annual
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$80.00M	USD	Annual
Distributions paid to noncontrolling interests	`PaymentsOfDividendsMinorityInterest`	$218.00M	USD	Annual
Distributions paid to noncontrolling interests	`PaymentsOfDividendsMinorityInterest`	$258.00M	USD	Annual
Distributions paid to noncontrolling interests	`PaymentsOfDividendsMinorityInterest`	$110.00M	USD	Annual
Proceeds from sale of noncontrolling interests	`ProceedsFromSaleOfInterestInCorporateUnit`	$31.00M	USD	Annual
Proceeds from sale of noncontrolling interests	`ProceedsFromSaleOfInterestInCorporateUnit`	$11.00M	USD	Annual
Proceeds from sale of noncontrolling interests	`ProceedsFromSaleOfInterestInCorporateUnit`	$22.00M	USD	Annual
Purchases of noncontrolling interests	`PaymentsToMinorityShareholders`	$186.00M	USD	Annual
Purchases of noncontrolling interests	`PaymentsToMinorityShareholders`	$729.00M	USD	Annual
Purchases of noncontrolling interests	`PaymentsToMinorityShareholders`	$268.00M	USD	Annual
Proceeds from exercise of stock options and employee stock purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$4.00M	USD	Annual
Proceeds from exercise of stock options and employee stock purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$7.00M	USD	Annual
Proceeds from exercise of stock options and employee stock purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$15.00M	USD	Annual
Other items, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$29.00M	USD	Annual
Other items, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$16.00M	USD	Annual
Other items, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$37.00M	USD	Annual
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-1.33B	USD	Annual
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$232.00M	USD	Annual
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$454.00M	USD	Annual
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-105.00M	USD	Annual
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$360.00M	USD	Annual
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$163.00M	USD	Annual
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$716.00M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$356.00M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$611.00M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$193.00M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$716.00M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$356.00M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$611.00M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$193.00M	USD	Point-in-time
Interest paid, net of capitalized interest	`InterestPaidNet`	$932.00M	USD	Annual
Interest paid, net of capitalized interest	`InterestPaidNet`	$939.00M	USD	Annual
Interest paid, net of capitalized interest	`InterestPaidNet`	$859.00M	USD	Annual
Income tax payments, net	`IncomeTaxesPaidNet`	$7.00M	USD	Annual
Income tax payments, net	`IncomeTaxesPaidNet`	$56.00M	USD	Annual
Income tax payments, net	`IncomeTaxesPaidNet`	$33.00M	USD	Annual

Stockholders Equity 28 line items

Line Item	Tag	Value	Unit	Period
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.08B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$539.00M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$785.00M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$958.00M	USD	Point-in-time
Net income (loss)	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$-54.00M	USD	Annual
Net income (loss)	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$-559.00M	USD	Annual
Net income (loss)	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$-88.00M	USD	Annual
Distributions paid to noncontrolling interests	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$111.00M	USD	Annual
Distributions paid to noncontrolling interests	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$50.00M	USD	Annual
Distributions paid to noncontrolling interests	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$123.00M	USD	Annual
Contributions from noncontrolling interests	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$3.00M	USD	Annual
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-94.00M	USD	Annual
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$54.00M	USD	Annual
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$18.00M	USD	Annual
Accretion of redeemable noncontrolling interests	`AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock`	$33.00M	USD	Annual
Purchases (sales) of businesses and noncontrolling interests	`AdjustmentsToAdditionalPaidInCapitalPurchaseSaleOfJointVentureInterest`	$106.00M	USD	Annual
Purchases (sales) of businesses and noncontrolling interests	`AdjustmentsToAdditionalPaidInCapitalPurchaseSaleOfJointVentureInterest`	$252.00M	USD	Annual
Purchases (sales) of businesses and noncontrolling interests	`AdjustmentsToAdditionalPaidInCapitalPurchaseSaleOfJointVentureInterest`	$3.00M	USD	Annual
Purchase accounting adjustments	`NoncontrollingInterestPurchaseAccountingAdjustment`	$225.00M	USD	Annual
Repurchases of common stock	`StockRepurchasedDuringPeriodValue`	$40.00M	USD	Annual
Cumulative effect of accounting change	`NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification`	$56.00M	USD	Annual
Stock-based compensation expense and issuance of common stock	`StockIssuedDuringPeriodValueShareBasedCompensation`	$59.00M	USD	Annual
Stock-based compensation expense and issuance of common stock	`StockIssuedDuringPeriodValueShareBasedCompensation`	$78.00M	USD	Annual
Stock-based compensation expense and issuance of common stock	`StockIssuedDuringPeriodValueShareBasedCompensation`	$52.00M	USD	Annual
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.08B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$539.00M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$785.00M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$958.00M	USD	Point-in-time

Comprehensive Income 33 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$-320.00M	USD	Annual
Net income (loss)	`ProfitLoss`	$78.00M	USD	Annual
Net income (loss)	`ProfitLoss`	$176.00M	USD	Annual
Adjustments for defined benefit plans	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax`	$-3.00M	USD	Annual
Adjustments for defined benefit plans	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax`	$-42.00M	USD	Annual
Adjustments for defined benefit plans	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax`	$73.00M	USD	Annual
Amortization of net actuarial loss included in other non-operating expense, net	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAmortizationOfNetActuarialGainLossArisingDuringPeriodBeforeTax`	$12.00M	USD	Annual
Amortization of net actuarial loss included in other non-operating expense, net	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAmortizationOfNetActuarialGainLossArisingDuringPeriodBeforeTax`	$12.00M	USD	Annual
Amortization of net actuarial loss included in other non-operating expense, net	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAmortizationOfNetActuarialGainLossArisingDuringPeriodBeforeTax`	$14.00M	USD	Annual
Unrealized gains (losses) on securities held as available-for-sale	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$-2.00M	USD	Annual
Unrealized gains (losses) on securities held as available-for-sale	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$6.00M	USD	Annual
Unrealized gains (losses) on securities held as available-for-sale	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$2.00M	USD	Annual
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax`	$15.00M	USD	Annual
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax`	$5.00M	USD	Annual
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax`	$-53.00M	USD	Annual
Other comprehensive income (loss) before income taxes	`OtherComprehensiveIncomeLossBeforeTax`	$-112.00M	USD	Annual
Other comprehensive income (loss) before income taxes	`OtherComprehensiveIncomeLossBeforeTax`	$18.00M	USD	Annual
Other comprehensive income (loss) before income taxes	`OtherComprehensiveIncomeLossBeforeTax`	$77.00M	USD	Annual
Income tax benefit (expense) related to items of other comprehensive income (loss)	`OtherComprehensiveIncomeLossTax`	$23.00M	USD	Annual
Income tax benefit (expense) related to items of other comprehensive income (loss)	`OtherComprehensiveIncomeLossTax`	$-18.00M	USD	Annual
Income tax benefit (expense) related to items of other comprehensive income (loss)	`OtherComprehensiveIncomeLossTax`	-	USD	Annual
Total other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-94.00M	USD	Annual
Total other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$54.00M	USD	Annual
Total other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$18.00M	USD	Annual
Comprehensive net income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-266.00M	USD	Annual
Comprehensive net income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$96.00M	USD	Annual
Comprehensive net income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$82.00M	USD	Annual
Less: Comprehensive income attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$384.00M	USD	Annual
Less: Comprehensive income attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$218.00M	USD	Annual
Less: Comprehensive income attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$368.00M	USD	Annual
Comprehensive loss attributable to Tenet Healthcare Corporation common shareholders	`ComprehensiveIncomeNetOfTax`	$-650.00M	USD	Annual
Comprehensive loss attributable to Tenet Healthcare Corporation common shareholders	`ComprehensiveIncomeNetOfTax`	$-122.00M	USD	Annual
Comprehensive loss attributable to Tenet Healthcare Corporation common shareholders	`ComprehensiveIncomeNetOfTax`	$-286.00M	USD	Annual

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.